Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monika Schmidt

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Journal of Enzyme Inhibition and Medicinal Chemistry|January 20, 2021
Pyridinium-2-carbaldoximes with quinolinium carboxamide moiety are simultaneous reactivators of acetylcholinesterase and butyrylcholinesterase inhibited by nerve agent surrogatesHyun Myung Lee, Rudolf Andrys, Jakub Jonczyk, et al.
International Journal of Molecular Sciences|March 21, 2020
Benzothiazolyl Ureas are Low Micromolar and Uncompetitive Inhibitors of 17β-HSD10 with Implications to Alzheimer's Disease TreatmentMonika Schmidt, Ondrej Benek, Lucie Vinklarova, et al.
Archives of Toxicology|March 6, 2024
A-series agent A-234: initial in vitro and in vivo characterizationMartina Hrabinova, Jaroslav Pejchal, Vendula Hepnarova, et al.
International Journal of Molecular Sciences|June 4, 2020
Acetylcholinesterase Inhibition of Diversely Functionalized Quinolinones for Alzheimer's Disease TherapyÓscar M Bautista-Aguilera, Lhassane Ismaili, Mourad Chioua, et al.
Bioorganic & Medicinal Chemistry Letters|September 23, 2021
Derivatives of montanine-type alkaloids and their implication for the treatment of Alzheimer's disease: Synthesis, biological activity and in silico studyNegar Maafi, Filip Pidaný, Jana Maříková, et al.
International Journal of Molecular Sciences|August 7, 2021
Amaryllidaceae Alkaloids of Norbelladine-Type as Inspiration for Development of Highly Selective Butyrylcholinesterase Inhibitors: Synthesis, Biological Activity Evaluation, and Docking StudiesAbdullah Al Mamun, Filip Pidaný, Daniela Hulcová, et al.
The Journal of Clinical Investigation|August 2, 2012
Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infectionsAmandine Crequer, Anja Troeger, Etienne Patin, et al.
Archives of Toxicology|March 16, 2026
Next-generation broad-spectrum reactivators for effective countermeasure against organophosphorus poisoningJana Zdarova Karasova, Martina Hrabinova, Alzbeta Dlabkova, et al.
European Journal of Medicinal Chemistry|June 30, 2023
Development of submicromolar 17β-HSD10 inhibitors and their in vitro and in vivo evaluationOndrej Benek, Michaela Vaskova, Marketa Miskerikova, et al.
American Heart Journal|February 26, 2022
Randomized evaluation of decision support interventions for atrial fibrillation: Rationale and design of the RED-AF studyAubrey E Jones, Madeleine M McCarty, Juan P Brito, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Journal of Enzyme Inhibition and Medicinal Chemistry|January 20, 2021
Pyridinium-2-carbaldoximes with quinolinium carboxamide moiety are simultaneous reactivators of acetylcholinesterase and butyrylcholinesterase inhibited by nerve agent surrogatesHyun Myung Lee, Rudolf Andrys, Jakub Jonczyk, et al.
International Journal of Molecular Sciences|March 21, 2020
Benzothiazolyl Ureas are Low Micromolar and Uncompetitive Inhibitors of 17β-HSD10 with Implications to Alzheimer's Disease TreatmentMonika Schmidt, Ondrej Benek, Lucie Vinklarova, et al.
Archives of Toxicology|March 6, 2024
A-series agent A-234: initial in vitro and in vivo characterizationMartina Hrabinova, Jaroslav Pejchal, Vendula Hepnarova, et al.
International Journal of Molecular Sciences|June 4, 2020
Acetylcholinesterase Inhibition of Diversely Functionalized Quinolinones for Alzheimer's Disease TherapyÓscar M Bautista-Aguilera, Lhassane Ismaili, Mourad Chioua, et al.
Bioorganic & Medicinal Chemistry Letters|September 23, 2021
Derivatives of montanine-type alkaloids and their implication for the treatment of Alzheimer's disease: Synthesis, biological activity and in silico studyNegar Maafi, Filip Pidaný, Jana Maříková, et al.
International Journal of Molecular Sciences|August 7, 2021
Amaryllidaceae Alkaloids of Norbelladine-Type as Inspiration for Development of Highly Selective Butyrylcholinesterase Inhibitors: Synthesis, Biological Activity Evaluation, and Docking StudiesAbdullah Al Mamun, Filip Pidaný, Daniela Hulcová, et al.
The Journal of Clinical Investigation|August 2, 2012
Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infectionsAmandine Crequer, Anja Troeger, Etienne Patin, et al.
Archives of Toxicology|March 16, 2026
Next-generation broad-spectrum reactivators for effective countermeasure against organophosphorus poisoningJana Zdarova Karasova, Martina Hrabinova, Alzbeta Dlabkova, et al.
European Journal of Medicinal Chemistry|June 30, 2023
Development of submicromolar 17β-HSD10 inhibitors and their in vitro and in vivo evaluationOndrej Benek, Michaela Vaskova, Marketa Miskerikova, et al.
American Heart Journal|February 26, 2022
Randomized evaluation of decision support interventions for atrial fibrillation: Rationale and design of the RED-AF studyAubrey E Jones, Madeleine M McCarty, Juan P Brito, et al.
Pageof 6